ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$4.68
+0.13 (+2.86%)
Open$4.55
Previous Close$4.55
Day High$4.87
Day Low$4.43
52W High$6.91
52W Low$1.00
Volume—
Avg Volume250.9K
Market Cap165.58M
P/E Ratio—
EPS$-1.16
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+296.4% upside
Current
$4.68
$4.68
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.24M | 7.98M | 7.65M |
| Net Income | 1.80M | 1.81M | 1.71M |
| Profit Margin | 21.9% | 22.7% | 22.3% |
| EBITDA | 3.67M | 3.33M | 3.32M |
| Free Cash Flow | 1.39M | 970.9K | 896.1K |
| Rev Growth | -4.4% | +17.2% | +22.3% |
| Debt/Equity | 1.44 | 1.37 | 1.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |